Maxcyte (MXCT) Debt Ratio (2020)

Maxcyte (MXCT) reported Debt Ratio of 0.09 for Q4 2020.

Maxcyte (MXCT) Debt Ratio (2020) Analysis & Trends

Maxcyte (MXCT) has 1 years of Debt Ratio data on file, last reported at 0.09 in Q4 2020.

Debt Ratio for Q4 2020 came in at 0.09, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was 0.09 (changed N/A YoY), and the FY2020 annual result was 0.09, changed N/A from the prior year.
Debt Ratio was little changed at 0.09 in Q4 2020 per MXCT's latest filing.
Over five years, Debt Ratio peaked at 0.09 in Q4 2020 and troughed at 0.09 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.31
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.31
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.30
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.27
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.18
10	Maxcyte	127.72 Mn	127.72 Mn	8.08 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	0.09